China's Medical Device Market: Coping with Evolving Regulatory Challenges

Time to Read: 1 minutes Practices: China Life Sciences

Printer-Friendly Version

Ask a senior manager of a MedTech company in China what keeps her or him awake at night and “regulatory changes” will invariably be among the first things mentioned. In fact, in McKinsey’s 2016 survey of MedTech CEOs, regulation tops the list of critical issues MedTech leaders face. Continue reading.

If you would like to discuss the foregoing or any other related matter, please contact Katherine Wang or your usual Ropes & Gray advisor.

Printer-Friendly Version

Cookie Settings